Gladius Capital Management LP Icosavax, Inc. Transaction History

Gladius Capital Management LP

  • $166 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Dec 18, 2023
BUY
$2.32 - $10.97 $25,543 - $120,779
11,010 New
11,010 $87,000
Q4 2022

Feb 02, 2023
BUY
$2.32 - $10.97 $7,382 - $34,906
3,182 Added 40.65%
11,010 $88,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $9.21 $24,188 - $72,095
7,828 New
7,828 $25,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email